Tag: Providence Therapeutics
Australia-based manufacturing to deliver custom mRNA vaccines for brain cancer trial
Southern RNA and Providence Therapeutics have announced their support for a world-first clinical trial evaluating personalised mRNA cancer vaccines for children with advanced and treatment-resistant brain tumours, in what the companies describe as a significant step for both clinical research and mRNA manufacturing capability.
Featured Article
Responding to manufacturing demand and performance signals
Australian manufacturers are navigating a challenging environment. Just as output had returned to growth, higher fuel and freight costs, rising input prices and global supply chain disruption renewed pressure on margins and cash flow.
